22-G-Procore Needle for the Diagnosis of SETs of the Upper GI Tract (PRO-SET)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01726010
Verified September 2012 by Technische Universität München. Recruitment status was: Recruiting
The goal of this prospective study is to evaluate the feasibility of the 22-G Core Biopsy Needle with reverse bevel (Procore TM) in biopsy sampling of subepithelial tumors of the upper gastrointestinal tract.
Condition or disease
Subepithelial Tumors of the Upper Gastrointestinal Tract
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years and older (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Patient age 18 years and older
All patients with subepithelial tumors of the upper GI tract (maximum size: 3 cm)